Witryna1 cze 2024 · SAN FRANCISCO, CA & MILAN, ITALY / ACCESSWIRE / June 1, 2024 / Napo EU S.p.A. ("Napo EU"), the Italian subsidiary of Napo Pharmacuticals, Inc. … WitrynaNapo Therapeutics is a European Company headquartered in Milan. Our majority shareholder is Napo Pharmaceuticals, a wholly owned subsidiary of Jaguar Health, …
CATERINA DI FRANCO’S Post - LinkedIn
Witryna15 lut 2024 · Jaguar Health is the majority shareholder of Napo Therapeutics S.p.A., an Italian corporation established by Jaguar Health in Milan, Italy in 2024 that focuses on … WitrynaNapo Pharmaceuticals, Inc. 200 Pine Street, Suite 400 San Francisco, CA 94104 Tel: (415) 963-9938 Fax: (415) 371-8311. Napo Pharmaceuticals, Inc. is a wholly-owned … mwd architects
AQVA (2024) by Delfi Meedia ajakirjad - Issuu
Witryna26 wrz 2024 · Chief Regulatory Officer presso Napo Therapeutics SpA // President #HBAMilan. View articles by Annabella Amatulli. Prima dell'inizio di una nuova … Witryna17 gru 2024 · SAN FRANCISCO, CA - Jaguar Health, Inc. (NASDAQ:JAGX) announced that the name of its majority owned subsidiary changed from Napo EU S.p.A. to Napo Therapeutics S.p.A. effective December 17, 2024.Napo Therapeutics is a European specialty drug development and marketing company based in Milan, Italy. 'Our … Witryna20 gru 2024 · December 20, 2024 - 8:30 am. SAN FRANCISCO, CA / ACCESSWIRE / December 20, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the name of its majority owned subsidiary changed from Napo EU S.p.A. to Napo Therapeutics S.p.A. effective December 17, 2024. Napo Therapeutics is a … mwd board agenda